{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:34:19Z","timestamp":1791297259418,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2009.03.007","type":"journal-article","created":{"date-parts":[[2009,3,14]],"date-time":"2009-03-14T10:23:01Z","timestamp":1237026181000},"page":"2746-2754","source":"Crossref","is-referenced-by-count":71,"title":["A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability"],"prefix":"10.1016","volume":"27","author":[{"given":"Jian-Jong","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Len","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Teh","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2009.03.007_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0264-410X(00)00037-2","article-title":"New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO\/CVI meeting, Bangkok, Thailand, 13\u201315 October 1998","volume":"18","author":"Tsai","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.007_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/13550280390194037","article-title":"Recent advances in Japanese encephalitis","volume":"9","author":"Solomon","year":"2003","journal-title":"J Neurovirol"},{"issue":"12 Suppl.","key":"10.1016\/j.vaccine.2009.03.007_bib3","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat Med"},{"issue":"9284","key":"10.1016\/j.vaccine.2009.03.007_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","article-title":"Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study","volume":"358","author":"Bista","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.03.007_bib5","first-page":"105","article-title":"Japanese encephalitis vaccines: current vaccines and future prospects","volume":"267","author":"Monath","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2009.03.007_bib6","series-title":"Fields virology","first-page":"1101","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2007"},{"key":"10.1016\/j.vaccine.2009.03.007_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0065-3527(03)60008-4","article-title":"Pathogenesis of flavivirus encephalitis","volume":"60","author":"Chambers","year":"2003","journal-title":"Adv Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2009.03.007_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJMra030476","article-title":"Flavivirus encephalitis","volume":"351","author":"Solomon","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.007_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.icb.7100012","article-title":"Immunopathology of flavivirus infections","volume":"85","author":"King","year":"2007","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.03.007_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/088282403322396082","article-title":"Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus","volume":"16","author":"Diamond","year":"2003","journal-title":"Viral Immunol"},{"issue":"19","key":"10.1016\/j.vaccine.2009.03.007_bib11","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1128\/JVI.01122-06","article-title":"Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion","volume":"80","author":"Samuel","year":"2006","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.03.007_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.molmed.2008.05.004","article-title":"Immunological headgear: antiviral immune responses protect against neuroinvasive West Nile virus","volume":"14","author":"Klein","year":"2008","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.03.007_bib13","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.03.007_bib14","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20031223","article-title":"A critical role for induced IgM in the protection against West Nile virus infection","volume":"198","author":"Diamond","year":"2003","journal-title":"J Exp Med"},{"issue":"15","key":"10.1016\/j.vaccine.2009.03.007_bib15","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+ T cells in control of West Nile virus infection","volume":"78","author":"Shrestha","year":"2004","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2009.03.007_bib16","doi-asserted-by":"crossref","first-page":"13323","DOI":"10.1128\/JVI.77.24.13323-13334.2003","article-title":"CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis","volume":"77","author":"Wang","year":"2003","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2009.03.007_bib17","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1128\/JVI.78.14.7737-7747.2004","article-title":"The host response to West Nile virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway","volume":"78","author":"Fredericksen","year":"2004","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.03.007_bib18","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1128\/JVI.80.6.2913-2923.2006","article-title":"West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling","volume":"80","author":"Fredericksen","year":"2006","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.007_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.micinf.2005.06.014","article-title":"Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation","volume":"8","author":"Chang","year":"2006","journal-title":"Microbes Infect"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2009.03.007_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.83391-0","article-title":"Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures","volume":"89","author":"Randall","year":"2008","journal-title":"J Gen Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.03.007_bib21","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6","author":"Borden","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2009.03.007_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1099\/vir.0.18654-0","article-title":"Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus","volume":"84","author":"Lobigs","year":"2003","journal-title":"J Gen Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2009.03.007_bib23","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","article-title":"Alpha\/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival","volume":"79","author":"Samuel","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.03.007_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.micro.55.1.255","article-title":"Viruses and interferons","volume":"55","author":"Sen","year":"2001","journal-title":"Annu Rev Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.03.007_bib25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1089\/vim.2004.17.498","article-title":"Inverse interference: how viruses fight the interferon system","volume":"17","author":"Weber","year":"2004","journal-title":"Viral Immunol"},{"issue":"17","key":"10.1016\/j.vaccine.2009.03.007_bib26","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.1128\/JVI.78.17.9285-9294.2004","article-title":"Blocking of the alpha interferon-induced Jak\u2013Stat signaling pathway by Japanese encephalitis virus infection","volume":"78","author":"Lin","year":"2004","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.03.007_bib27","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1128\/JVI.02714-05","article-title":"Blocking of interferon-induced Jak\u2013Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism","volume":"80","author":"Lin","year":"2006","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.03.007_bib28","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1128\/JVI.79.3.1343-1350.2005","article-title":"West Nile virus inhibits the signal transduction pathway of alpha interferon","volume":"79","author":"Guo","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.03.007_bib29","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/JVI.79.3.1934-1942.2005","article-title":"Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins","volume":"79","author":"Liu","year":"2005","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2009.03.007_bib30","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.1128\/JVI.00768-06","article-title":"Resistance to alpha\/beta interferon is a determinant of West Nile virus replication fitness and virulence","volume":"80","author":"Keller","year":"2006","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.007_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/viro.1996.0457","article-title":"Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro","volume":"223","author":"Chen","year":"1996","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.007_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0168-1702(96)01343-3","article-title":"A highly attenuated strain of Japanese encephalitis virus induces a protective immune response in mice","volume":"44","author":"Lin","year":"1996","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.vaccine.2009.03.007_bib33","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(00)81289-1","article-title":"Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease","volume":"84","author":"Durbin","year":"1996","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.vaccine.2009.03.007_bib34","first-page":"857","article-title":"Comparative study of mouse brains infected with Japanese encephalitis virus by intracerebral or intraperitoneal inoculation","volume":"71","author":"Hase","year":"1990","journal-title":"Int J Exp Pathol"},{"issue":"35","key":"10.1016\/j.vaccine.2009.03.007_bib35","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1021\/bi00487a002","article-title":"Self-cleavage of hepatitis delta virus genomic strand RNA is enhanced under partially denaturing conditions","volume":"29","author":"Rosenstein","year":"1990","journal-title":"Biochemistry"},{"issue":"23","key":"10.1016\/j.vaccine.2009.03.007_bib36","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1093\/nar\/19.23.6519","article-title":"Self-cleavage of a 71 nucleotide-long ribozyme derived from hepatitis delta virus genomic RNA","volume":"19","author":"Thill","year":"1991","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.vaccine.2009.03.007_bib37","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1073\/pnas.88.12.5139","article-title":"Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus","volume":"88","author":"Lai","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.007_bib38","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2144\/00295bm08","article-title":"Generation of deletion and point mutations with one primer in a single cloning step","volume":"29","author":"Makarova","year":"2000","journal-title":"Biotechniques"},{"issue":"13","key":"10.1016\/j.vaccine.2009.03.007_bib39","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1073\/pnas.89.13.6070","article-title":"Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses","volume":"89","author":"Spriggs","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.007_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.007_bib41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/viro.2001.0986","article-title":"Highly sulfated forms of heparin sulfate are involved in Japanese encephalitis virus infection","volume":"286","author":"Su","year":"2001","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.007_bib42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/viro.2001.1114","article-title":"Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism","volume":"289","author":"Diamond","year":"2001","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.vaccine.2009.03.007_bib43","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1128\/JVI.74.11.4957-4966.2000","article-title":"Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons","volume":"74","author":"Diamond","year":"2000","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.007_bib44","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/infdis\/171.5.1144","article-title":"Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA","volume":"171","author":"Sumiyoshi","year":"1995","journal-title":"J Infect Dis"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2009.03.007_bib45","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1099\/vir.0.80638-0","article-title":"Characterization of the E-138 (Glu\/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone","volume":"86","author":"Zhao","year":"2005","journal-title":"J Gen Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2009.03.007_bib46","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1128\/JVI.78.15.8271-8280.2004","article-title":"Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses","volume":"78","author":"Lee","year":"2004","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.03.007_bib47","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.4049\/jimmunol.179.12.8403","article-title":"West Nile virus envelope protein inhibits dsRNA-induced innate immune responses","volume":"179","author":"Arjona","year":"2007","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.03.007_bib48","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/JVI.66.9.5425-5431.1992","article-title":"Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates","volume":"66","author":"Sumiyoshi","year":"1992","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.007_bib49","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/viro.2000.0793","article-title":"A new strategy in design of +RNA virus infectious clones enabling their stable propagation in E. coli","volume":"281","author":"Yamshchikov","year":"2001","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.vaccine.2009.03.007_bib50","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1128\/JVI.77.11.6450-6465.2003","article-title":"Development and application of a reverse genetics system for Japanese encephalitis virus","volume":"77","author":"Yun","year":"2003","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2009.03.007_bib51","doi-asserted-by":"crossref","first-page":"13963","DOI":"10.1128\/JVI.79.22.13963-13973.2005","article-title":"Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells","volume":"79","author":"Cai","year":"2005","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T19:44:18Z","timestamp":1589658258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09003843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":51,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0264410X09003843"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.03.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}